Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite

A Double-blind, Randomised Comparison of the Anti-emetic Efficacy of Two Intravenous Doses of Dolasetron Mesilate and Granisetron in Patients Receiving High Dose Cisplatin Chemotherapy

By on behalf of the European Dolasetron Comparative Study Group   Audhuy B.   Cappelaere P.   Martin M.   Cervantes A.   Fabbro M.   Riviere A.   Khayat D.   Bleiberg H.   Faraldi M.   Claverie N.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 807-813

Elsevier

Access to resources Recommend Favorite

Combination Chemotherapy with Etoposide, Cisplatin, and Doxorubicin in Mixed Mullerian Tumors of the Adnexa

By Cass I.   Resnik E.   Chambers J.T.   Chambers S.K.   Carcangiu M.L.   Kohorn E.I.   Schwartz P.E.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 309-314

Academic Press

Access to resources Recommend Favorite

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

By Goldberg J.M.   Piver M.S.   Hempling R.E.   Recio F.O.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 312-317

Academic Press

Access to resources Recommend Favorite

High-dose Carboplatin and Etoposide for Salvage Chemotherapy of Germ Cell Tumours

By Dearnaley D.P.   Lampe H.   Price A.   Mehta J.   Powles R.   Nicholls J.   Horwich A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 717-723

Elsevier

Access to resources Recommend Favorite